During the past decade, Hospital Vithas Internacional Medimar conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Vithas Internacional Medimar" are "Rhinitis" (1 trials), "Rhinoconjunctivitis" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Hospital Vithas Internacional Medimar" in a lesser frequency.

Most popular intervention types in "Hospital Vithas Internacional Medimar" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Best Supportive Care" (1 trials), "Following the planned interim analysis for this study: Avelumab" (1 trials), "MM09 Mannosylated 10.000 subcutaneous" (1 trials) and "MM09 Mannosylated 10.000 sublingual" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Vithas Internacional Medimar" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Vithas Internacional Medimar". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Vithas Internacional Medimar, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Vithas Internacional Medimar, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".